Liver News and Research

RSS

Jefferson scientists discover way to immunize mice against metastatic disease

Taking advantage of the fact that the intestines have a separate immune system from the rest of the body, scientists at the Kimmel Cancer Center at Jefferson in Philadelphia have found a way to immunize mice against the development of metastatic disease.

24 Jun 2008

Cells have an appetite for micro-doughnuts

Just like humans, liver cells can't resist eating just one or two small doughnuts, say chemists from Scotland in the Royal Society of Chemistry journal Chemical Communications.

24 Jun 2008

Lids on glass jars containing food under suspicion

Following an investigation by the consumer group Choice into foods in glass jars, food giant Heinz has withdrawn two baby food products from the Australian market.

24 Jun 2008

New findings show obesity-related complications improve six months following gastric banding procedure

Teenagers' obesity-related medical complications improve just six months after laparoscopic gastric banding surgery, according to outcomes data presented this week.

19 Jun 2008

Scientists identify proteins in mice that might act as biomarkers for growth hormone

Ohio University scientists have identified several proteins in mice that might act as biomarkers for growth hormone. The research could be the first step to finding a more reliable way to detect recombinant human growth hormone (rhGH), which some athletes and teenagers use illegally to boost muscle and reduce fat.

17 Jun 2008

Drink up that coffee to reduce your risk of a heart attack!

According to new research drinking coffee on a long-term basis does not increase the risk of early death and may in fact reduce the risk of dying from heart disease.

17 Jun 2008

Gene radiotherapy system shows promise for fighting treatment-resistant cancer cells

A gene radiotherapy system that detects and treats cancer cells that are resistant to traditional forms of chemotherapy and radiation showed success in the laboratory and could eventually prove beneficial for cancer patients, according to researchers at the Society of Nuclear Medicine's 55th Annual Meeting.

16 Jun 2008

Radioimmunotherapy targeting viral antigens shows potential to treat or prevent viral cancers

A new study, presented at the Society of Nuclear Medicine's 55th Annual Meeting, shows that radioimmunotherapy (RIT) targeting viral antigens offers a novel option to treat-or even prevent-many viral cancers by targeting cancer cells expressing viral antigens or infected cells before they convert into malignancy.

16 Jun 2008

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.

16 Jun 2008

Nanoparticles trigger built-in cell-death signal to overcome drug resistance

One of the most vexing problems in treating cancer is the propensity of tumors to develop resistance to a wide range of anticancer drugs. Over 70 percent of ovarian cancer patients, for example, have drug-resistant tumors at the time of their initial diagnosis, and virtually all patients who relapse have drug-resistant tumors.

15 Jun 2008

Age-adjusted death rates in U.S. down sharply in 2006

Age-adjusted death rates in the United States dropped significantly between 2005 and 2006 and life expectancy hit another record high, according to preliminary death statistics released today by CDC's National Center for Health Statistics.

11 Jun 2008

World experts in specialized radiation therapy to cather at University of Rochester Medical Center

Cancer survivor Jarod Finlay will share his experiences as the first patient to undergo an investigational procedure - stereotactic body radiation therapy - during a conference of world experts on the procedure this Friday and Saturday at the University of Rochester Medical Center.

11 Jun 2008

Researchers block the transmission of malaria in animal tests

By disrupting the potassium channel of the malaria parasite, a team of researchers has been able to prevent the malaria parasites from forming in mosquitoes and has thereby broken the cycle of infection during recent animal tests.

10 Jun 2008

Mylan announces final FDA approval for Zaleplon capsules, generic version of Sonata

Mylan Inc. has announced that its subsidiary, Genpharm ULC, has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Zaleplon Capsules, 5 mg and 10 mg.

9 Jun 2008

Calls for parents of vegan girl with severe rickets to face court

The parents of a young British girl brought up on a strict vegan diet could face court after the child was admitted to hospital with a degenerative bone condition.

9 Jun 2008

Health policy for men in the pipeline

Plans are in the pipeline to raise awareness of health issues which affect men in particular.

9 Jun 2008

Alcohol halves the risk of rheumatoid arthritis

Research from scientists in Sweden has found that drinking alcohol halves the risk of developing rheumatoid arthritis.

5 Jun 2008

Legal action proposed against parents who let children drink alcohol at home

The British Government is considering proposals which could include legal action against parents who allow their children to drink alcohol at home.

3 Jun 2008

How the cholesterol-lowering drug ezetimibe (Zetia) works

A new study in the June issue of Cell Metabolism, a Cell Press publication, sheds light on the action of the drug ezetimibe (trade name Zetia), which is used to treat high cholesterol. Ezetimibe is unique among cholesterol-lowering drugs in that it works by cutting the amount of cholesterol taken in from the diet rather than by blocking cholesterol's manufacture in the body.

3 Jun 2008

Chronic inflammation of the intestine or stomach damages DNA

Chronic inflammation of the intestine or stomach can damage DNA, increasing the risk of cancer, MIT scientists have confirmed.

2 Jun 2008

Liver News and Research

Jefferson scientists discover way to immunize mice against metastatic disease

Cells have an appetite for micro-doughnuts

Lids on glass jars containing food under suspicion

New findings show obesity-related complications improve six months following gastric banding procedure

Scientists identify proteins in mice that might act as biomarkers for growth hormone

Drink up that coffee to reduce your risk of a heart attack!

Gene radiotherapy system shows promise for fighting treatment-resistant cancer cells

Radioimmunotherapy targeting viral antigens shows potential to treat or prevent viral cancers

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

Nanoparticles trigger built-in cell-death signal to overcome drug resistance

Age-adjusted death rates in U.S. down sharply in 2006

World experts in specialized radiation therapy to cather at University of Rochester Medical Center

Researchers block the transmission of malaria in animal tests

Mylan announces final FDA approval for Zaleplon capsules, generic version of Sonata

Calls for parents of vegan girl with severe rickets to face court

Health policy for men in the pipeline

Alcohol halves the risk of rheumatoid arthritis

Legal action proposed against parents who let children drink alcohol at home

How the cholesterol-lowering drug ezetimibe (Zetia) works

Chronic inflammation of the intestine or stomach damages DNA

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News